Management of Dyslipidemias in Patients with Diabetes and Chronic Kidney Disease
نویسندگان
چکیده
منابع مشابه
In-Depth Review Management of Dyslipidemias in Patients with Diabetes and Chronic Kidney Disease
Cardiovascular disease (CVD) is the leading cause of death in patients with stage 5 chronic kidney disease (CKD), and the mortality rate in stage 5 CKD is even higher in patients with diabetes. CVD risk reduction includes control of hyperglycemia, dyslipidemia, and BP. An LDL cholesterol goal of 70 mg/dl has been suggested for such high-risk patients. Most studies that have showed CVD risk redu...
متن کاملManagement of diabetes mellitus in patients with chronic kidney disease
Glycemic control is essential to delay or prevent the onset of diabetic kidney disease. There are a number of glucose-lowering medications available but only a fraction of them can be used safely in chronic kidney disease and many of them need an adjustment in dosing. The ideal target hemoglobin A1c is approximately 7 % but this target is adjusted based on the needs of the patient. Diabetes con...
متن کامل[Diabetes management issues for patients with chronic kidney disease].
Chronic kidney disease is in continuous increase and can be found in up to 23% of patients with diabetes. Glycemic control is difficult to assess and medication therapy for diabetes may require dose adjustments part of the alteration of drug's pharmacokinetics and the insulin resistance which is predicting cardiovascular events. The recommended hemoglobin A1c goal is also lower than 7.0% withou...
متن کاملDiabetes Management Issues for Patients With Chronic Kidney Disease
Chronic kidney disease (CKD) is a common condition that is estimated to affect 11% of the U.S. population, or 19 million people, and > 50 million people worldwide. Similarly, diabetes is of an epidemic scale, with prevalence estimates of 20 million people in the United States and 171 million people worldwide. Diabetes is often associated with CKD, and for 45% of patients who receive dialysis th...
متن کاملDyslipidemias in chronic kidney disease: Current guidelines and future perspectives
Introduction Dyslipidemia is a major problem in chronic kidney disease (CKD) and haemodialysis patients. Although there has been much progress and reduction in the prevalence of dyslipidemia after the Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel), there were few specifi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Journal of the American Society of Nephrology
سال: 2006
ISSN: 1555-9041,1555-905X
DOI: 10.2215/cjn.00780306